Kiadis Pharma kondigt drie presentaties over K-NK-celtherapieplatform op ASCO 2020

NEXT STORY
Altimmune Announces First Quarter 2020 Financial Results and Provides a Business Update
PREV STORY
MacroGenics Announces Preliminary Clinical Results from MGD013 and MGC018 to be Presented at the ASCO Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunology Market to Hit USD 158.69 Billion with 8.1% CAGR by 2028 Backed by Increasing Demand for Biosimilars Globally, reports Fortune Business Insights™

author_avatar
NASDAQ Market News

10x Genomics Reports Second Quarter 2021 Financial Results

author_avatar
NASDAQ Market News

Clearlake Capital-Backed Provation Acquires endoPRO Software Portfolio from PENTAX Medical

author_avatar
NASDAQ Market News